Vanguard Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.99M | Sell |
|
|||||
|
2025
Q1 | $2.51M | Buy |
|
|||||
|
2024
Q4 | $7.29M | Buy |
|
|||||
|
2024
Q3 | $13.7M | Sell |
|
|||||
|
2024
Q2 | $11.7M | Buy |
|
|||||
|
2024
Q1 | $18.5M | Buy |
|
|||||
|
2023
Q4 | $10.2M | Buy |
|
|||||
|
2023
Q3 | $9.56M | Buy |
|
|||||
|
2023
Q2 | $7.78M | Buy |
|
|||||
|
2023
Q1 | $7.61M | Sell |
|
|||||
|
2022
Q4 | $1.41M | Buy |
|
|||||
|
2022
Q3 | $3.6M | Sell |
|
|||||
|
2022
Q2 | $6.46M | Buy |
|
|||||
|
2022
Q1 | $2M | Buy |
|
|||||
|
2021
Q4 | $3.33M | Sell |
|
|||||
|
2021
Q3 | $7.08M | Buy |
|
|||||
|
2021
Q2 | $5.71M | Sell |
|
|||||
|
2021
Q1 | $6.75M | Buy |
|
|||||
|
2020
Q4 | $6.38M | Buy |
|
|||||
|
2020
Q3 | $7.81M | Buy |
|